Filter News
Area of Research
- (-) Building Technologies (2)
- (-) Fusion and Fission (9)
- (-) Isotopes (6)
- Advanced Manufacturing (7)
- Biological Systems (2)
- Biology and Environment (78)
- Clean Energy (142)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Energy Sciences (2)
- Functional Materials for Energy (2)
- Fusion Energy (2)
- Materials (60)
- Materials for Computing (9)
- National Security (8)
- Neutron Science (24)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Supercomputing (67)
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (6)
- (-) Composites (1)
- (-) Energy Storage (4)
- (-) Exascale Computing (1)
- (-) Frontier (1)
- (-) Sustainable Energy (6)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Artificial Intelligence (1)
- Biology (1)
- Buildings (4)
- Chemical Sciences (4)
- Climate Change (1)
- Computer Science (3)
- Critical Materials (1)
- Decarbonization (2)
- Environment (3)
- Fossil Energy (1)
- Fusion (22)
- Grid (2)
- High-Performance Computing (2)
- Irradiation (1)
- Isotopes (25)
- ITER (6)
- Materials (5)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (1)
- National Security (1)
- Net Zero (1)
- Neutron Science (1)
- Nuclear Energy (29)
- Partnerships (3)
- Physics (1)
- Security (2)
- Simulation (3)
- Space Exploration (4)
- Transportation (2)
Media Contacts
![High voltage power lines carry electricity generated by the Tennessee Valley Authority to ORNL. Credit: Dobie Gillispie/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-02/Powerlines_resized.jpg?h=c74750f6&itok=33NqDqGh)
ORNL and the Tennessee Valley Authority, or TVA, are joining forces to advance decarbonization technologies from discovery through deployment through a new memorandum of understanding, or MOU.
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![An algorithm developed and field-tested by ORNL researchers uses machine learning to maintain homeowners’ preferred temperatures year-round while minimizing energy costs. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-07/2019-P07408_2.jpg?h=8f9cfe54&itok=jBvKdqIv)
Oak Ridge National Laboratory researchers designed and field-tested an algorithm that could help homeowners maintain comfortable temperatures year-round while minimizing utility costs.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Verónica Melesse Vergara speaks with third and fourth graders at East Side Intermediate School in Brownsville. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-02/EWeek_vergara_0.jpg?h=c44fcfa1&itok=-FdYpHed)
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.